{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:34:20Z","timestamp":1789788860287,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00296-020-04606-4","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T13:02:39Z","timestamp":1590238959000},"page":"943-949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Targeted high concentration botulinum toxin A injections in patients with Raynaud\u2019s phenomenon: a retrospective single-centre experience"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3445-0627","authenticated-orcid":false,"given":"Mahalakshmi","family":"Nagarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,23]]},"reference":[{"key":"4606_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jhsa.2008.11.026","volume":"34","author":"A Fregene","year":"2009","unstructured":"Fregene A, Ditmars D, Siddiqui A (2009) Botulinum toxin type A: a treatment option for digital Ischemia in patients with Raynaud\u2019s phenomenon. J Hand Surg Am 34:446\u2013452. https:\/\/doi.org\/10.1016\/j.jhsa.2008.11.026","journal-title":"J Hand Surg Am"},{"key":"4606_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.clindermatol.2018.04.007","volume":"36","author":"T Stringer","year":"2018","unstructured":"Stringer T, Femia AN (2018) Raynaud\u2019s phenomenon: current concepts. Clin Dermatol 36:498\u2013507. https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.007","journal-title":"Clin Dermatol"},{"key":"4606_CR3","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.jhsa.2010.09.019","volume":"35","author":"MW Neumeister","year":"2010","unstructured":"Neumeister MW (2010) Botulinum toxin type a in the treatment of Raynaud\u2019s phenomenon. J Hand Surg Am 35:2085\u20132092. https:\/\/doi.org\/10.1016\/j.jhsa.2010.09.019","journal-title":"J Hand Surg Am"},{"key":"4606_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1346-8138.13030","volume":"43","author":"SI Motegi","year":"2016","unstructured":"Motegi SI, Yamada K, Toki S et al (2016) Beneficial effect of botulinum toxin A on Raynaud\u2019s phenomenon in Japanese patients with systemic sclerosis: a prospective, case series study. J Dermatol 43:56\u201362. https:\/\/doi.org\/10.1111\/1346-8138.13030","journal-title":"J Dermatol"},{"key":"4606_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2362.2004.01324.x","volume":"34","author":"T Sycha","year":"2004","unstructured":"Sycha T, Graninger M, Auff E, Schnider P (2004) Botulinum toxin in the treatment of Raynaud\u2019s phenomenon: a pilot study [1]. Eur J Clin Invest 34:312\u2013313","journal-title":"Eur J Clin Invest"},{"key":"4606_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.5114\/aoms.2015.48152","volume":"12","author":"P Zebryk","year":"2016","unstructured":"Zebryk P, Puszczewicz MJ (2016) Botulinum toxin A in the treatment of Raynaud\u2019s phenomenon: a systematic review. Arch Med Sci 12:864\u2013870","journal-title":"Arch Med Sci"},{"key":"4606_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.anplas.2011.11.001","volume":"58","author":"J Serri","year":"2013","unstructured":"Serri J, Legr\u00e9 R, Veit V et al (2013) Botulinum toxin type A contribution in the treatment of Raynaud\u2019s phenomenon due to systemic sclerosis. Ann Chir Plast Esthet 58:658\u2013662. https:\/\/doi.org\/10.1016\/j.anplas.2011.11.001","journal-title":"Ann Chir Plast Esthet"},{"key":"4606_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","volume":"119","author":"AL Van Beek","year":"2007","unstructured":"Van Beek AL, Lim PK, Gear AJL, Pritzker MR (2007) Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg 119:217\u2013226. https:\/\/doi.org\/10.1097\/01.prs.0000244860.00674.57","journal-title":"Plast Reconstr Surg"},{"key":"4606_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jaad.2013.06.029","volume":"69","author":"SN Jenkins","year":"2013","unstructured":"Jenkins SN, Neyman KM, Veledar E, Chen SC (2013) A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon. J Am Acad Dermatol 69:834\u2013835. https:\/\/doi.org\/10.1016\/j.jaad.2013.06.029","journal-title":"J Am Acad Dermatol"},{"key":"4606_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/PRS.0b013e3181a80576","volume":"124","author":"MW Neumeister","year":"2009","unstructured":"Neumeister MW, Chambers CB, Herron MS et al (2009) Botox therapy for ischemic digits. Plast Reconstr Surg 124:191\u2013200. https:\/\/doi.org\/10.1097\/PRS.0b013e3181a80576","journal-title":"Plast Reconstr Surg"},{"key":"4606_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/1753193413516242","volume":"39","author":"L Uppal","year":"2014","unstructured":"Uppal L, Dhaliwal K, Butler PE (2014) A prospective study of the use of botulinum toxin injections in the treatment of Raynaud\u2019s syndrome associated with scleroderma. J Hand Surg Eur 39:876\u2013880. https:\/\/doi.org\/10.1177\/1753193413516242","journal-title":"J Hand Surg Eur"},{"key":"4606_CR12","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s10067-019-04762-4","volume":"38","author":"K Dhaliwal","year":"2019","unstructured":"Dhaliwal K, Griffin MF, Salinas S et al (2019) Optimisation of botulinum toxin type a treatment for the management of Raynaud\u2019s phenomenon using a dorsal approach: a prospective case series. Clin Rheumatol 38:3669\u20133676. https:\/\/doi.org\/10.1007\/s10067-019-04762-4","journal-title":"Clin Rheumatol"},{"key":"4606_CR13","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/art.40123","volume":"69","author":"RJ Bello","year":"2017","unstructured":"Bello RJ, Cooney CM, Melamed E et al (2017) The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud\u2019s phenomenon: a randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol 69:1661\u20131669. https:\/\/doi.org\/10.1002\/art.40123","journal-title":"Arthritis Rheumatol"},{"key":"4606_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1558944717715119","volume":"13","author":"CS Pace","year":"2018","unstructured":"Pace CS, Merritt WH (2018) Extended periarterial sympathectomy: evaluation of long-term outcomes. Hand 13:395\u2013402","journal-title":"Hand"},{"key":"4606_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0363-5023(83)80161-0","volume":"8","author":"RF Morgan","year":"1983","unstructured":"Morgan RF, Reisman NR, Wilgis EFS (1983) Anatomic localization of sympathetic nerves in the hand. J Hand Surg Am 8:283\u2013288. https:\/\/doi.org\/10.1016\/S0363-5023(83)80161-0","journal-title":"J Hand Surg Am"},{"key":"4606_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0363-5023(80)80104-3","volume":"5","author":"AE Flatt","year":"1980","unstructured":"Flatt AE (1980) Digital artery sympathectomy. J Hand Surg Am 5:550\u2013556. https:\/\/doi.org\/10.1016\/S0363-5023(80)80104-3","journal-title":"J Hand Surg Am"},{"key":"4606_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s40674-014-0006-z","volume":"1","author":"FM Wigley","year":"2015","unstructured":"Wigley FM, Herrick AL (2015) Management of Raynaud\u2019s phenomenon and digital ulcers. Curr Treat Options Rheumatol 1:68\u201381. https:\/\/doi.org\/10.1007\/s40674-014-0006-z","journal-title":"Curr Treat Options Rheumatol"},{"key":"4606_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr-2017-219348","volume":"2018","author":"K Dhaliwal","year":"2018","unstructured":"Dhaliwal K, Griffin M, Denton CP, Butler PEM (2018) The novel use of botulinum toxin A for the treatment of Raynaud\u2019s phenomenon in the toes. BMJ Case Rep 2018:1\u20134. https:\/\/doi.org\/10.1136\/bcr-2017-219348","journal-title":"BMJ Case Rep"},{"key":"4606_CR19","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2147\/DDDT.S161113","volume":"12","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Liu Y, Hao Y et al (2018) The mechanism of botulinum A on Raynaud syndrome. Drug Des Devel Ther 12:1905\u20131915. https:\/\/doi.org\/10.2147\/DDDT.S161113","journal-title":"Drug Des Devel Ther"},{"key":"4606_CR20","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1460-9568.1994.tb00323.x","volume":"6","author":"TJ Coderre","year":"1994","unstructured":"Coderre TJ, Yashpal K (1994) Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-Glutamate and substance P in the rat formalin pain model. Eur J Neurosci 6:1328\u20131334. https:\/\/doi.org\/10.1111\/j.1460-9568.1994.tb00323.x","journal-title":"Eur J Neurosci"},{"key":"4606_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cps.2011.03.010","volume":"38","author":"TV Cartee","year":"2011","unstructured":"Cartee TV, Monheit GD (2011) An overview of botulinum toxins: past, present, and future. Clin Plast Surg 38:409\u2013426","journal-title":"Clin Plast Surg"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04606-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04606-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04606-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T23:13:24Z","timestamp":1621725204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04606-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,23]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4606"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04606-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,23]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients signed informed consent regarding publishing their photographs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}